Back to search
Secondarily Infected Traumatic Skin Lesions
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Secondarily Infected Traumatic Skin Lesions trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Secondarily Infected Traumatic Skin Lesions trials you may qualify forA national, prospective single arm phase II study investigating the pharmacokinetics and safety of the 2% TD1414 cream when applied 3 times daily for 7 days to…
An international, multi-centre, prospective three arm parallel-group, phase II proof of concept study comparing the efficacy and safety of two dosage regimens (…
To compare the safety and efficacy of Perrigo's product to an FDA approved product, and to Compare Both Active Treatments to a Vehicle Control in the Treatment…
The primary objective of this study is to determine the comparability of the safety and efficacy of Mupirocin Calcium Cream, 2% and Bactroban® Cream in subjects…
The purpose of this study is to provide further evidence of the clinical and bacteriological efficacy of retapamulin in the treatment of subjects with SITL or i…
The purpose of Study TOC110977 is to demonstrate clinical superiority of Retapamulin ointment, 1%, over placebo in patients with secondarily-infected traumatic…
This is an open label, multi-centre, non-interventional post-marketing surveillance.